Skip to main content
Clinical Trials/NCT06255808
NCT06255808
Active, not recruiting
Not Applicable

Development of Assist Tool for Breast Examination Using the Principle of Ultrasonic Sensor : A Development and Validation Study

Seoul National University Hospital1 site in 1 country200 target enrollmentOctober 5, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Breast Cancer
Sponsor
Seoul National University Hospital
Enrollment
200
Locations
1
Primary Endpoint
Device performance
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

The accuracy of breast examinations and ultrasonography performed clinically to detect breast mass varies greatly depending on the physician's skill level, and the accuracy of breast examinations by non-experts is particularly low. In this study, we aimed to validate whether the concurrent use of ultrasound sensor technology is an efficient strategy for the purpose of improving the sensitivity of detecting breast masses through breast examination.

Detailed Description

\[Background\] This research team would like to conduct this study based on the idea that the sensitivity of breast palpation can be improved by moving away from traditional breast palpation, which is simply performed by hand, and using auxiliary examination equipment based on ultrasonic sensor technology. In particular, our research team focused on the waveform of the ultrasound itself rather than the visual images obtained through the ultrasound device. In the existing breast ultrasound, the medical staff reads images created through ultrasound from multiple sensors to confirm the possibility of breast cancer, and this is read based on the medical staff\'s very subjective opinions. However, ultrasonic waveforms acquired through ultrasound can store information about the waveform as data and thus be implemented as objective values. \[Study design\] Prospective, multi-institutional \[Study protocol\] ① Preoperative ultrasound sensor-based diagnostic equipment was applied to 200 patients with breast mass among patients admitted to the breast surgery department, and prospectively obtained ultrasound echo signal data generated by the mass. ② For this purpose, the researcher uses equipment containing a single ultrasound sensor to manually scan the mass lesion area and no evidence disease area. ③ Diagnostic performance (judgment for presence or absence of a tumor) of diagnostic tool based on ultrasound sensor technology through an artificial intelligence algorithm designed based on ultrasound wavelength and frequency optimized for mass detection. \[Objectives\] 1. Primary endpoint Sensitivity/specificity/predictive value/accuracy/positive \& negative predictive of diagnostic performance 2. Secondary endpoint Artificial intelligence algorithm efficacy

Registry
clinicaltrials.gov
Start Date
October 5, 2024
End Date
April 5, 2025
Last Updated
last year
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Hyeong-Gon Moon

Professior

Seoul National University Hospital

Eligibility Criteria

Inclusion Criteria

  • female patients between 18 and 80 years of age who are scheduled for surgery after a tumor has been confirmed on breast ultrasound examination

Exclusion Criteria

  • Patients diagnosed with breast cancer after biopsy with non-mass enhancement or calcification
  • Inflammatory breast cancer
  • Patients whose cancer has invaded the skin and broken through
  • Patients with skin diseases
  • Women who refused to participate in the study

Outcomes

Primary Outcomes

Device performance

Time Frame: Within 1 year after the study participant registration deadline

Sensitivity/specificity/predictive value/accuracy/positive predictive value/ negative predictive value of diagnostic performance

Secondary Outcomes

  • Artificial intelligence algorithm efficacy(Within 2 year after the study participant registration deadline)

Study Sites (1)

Loading locations...

Similar Trials